Magnetar Financial LLC Has $3.10 Million Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Magnetar Financial LLC raised its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 139.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,417 shares of the medical instruments supplier’s stock after buying an additional 5,491 shares during the period. Magnetar Financial LLC’s holdings in West Pharmaceutical Services were worth $3,102,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of West Pharmaceutical Services by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock valued at $3,170,007,000 after purchasing an additional 104,740 shares during the last quarter. Artisan Partners Limited Partnership increased its stake in shares of West Pharmaceutical Services by 23.2% during the fourth quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock worth $690,530,000 after purchasing an additional 369,792 shares during the period. TD Asset Management Inc boosted its stake in West Pharmaceutical Services by 38.4% in the 4th quarter. TD Asset Management Inc now owns 659,560 shares of the medical instruments supplier’s stock valued at $232,244,000 after purchasing an additional 183,153 shares during the period. Findlay Park Partners LLP grew its holdings in West Pharmaceutical Services by 30.6% in the 1st quarter. Findlay Park Partners LLP now owns 597,106 shares of the medical instruments supplier’s stock valued at $236,281,000 after buying an additional 139,800 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in West Pharmaceutical Services by 6.8% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier’s stock worth $195,556,000 after buying an additional 37,702 shares during the period. 93.90% of the stock is currently owned by institutional investors.

Insider Activity

In related news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the sale, the vice president now directly owns 1,478 shares in the company, valued at approximately $443,400. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Price Performance

NYSE:WST opened at $306.73 on Tuesday. West Pharmaceutical Services, Inc. has a 52 week low of $265.00 and a 52 week high of $413.70. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The firm’s 50-day simple moving average is $303.10 and its 200 day simple moving average is $336.80. The firm has a market cap of $22.34 billion, a price-to-earnings ratio of 40.47, a P/E/G ratio of 10.58 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). The company had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business’s revenue for the quarter was down 6.9% compared to the same quarter last year. During the same period last year, the company posted $2.11 earnings per share. As a group, sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.